NEW MEDICINES LISTED ON THE PBS

Australians suffering from melanoma and multiple sclerosis have new treatment options, with new and amended PBS listings. 🔸 Tafinlar® (dabrafenib) and Mekinist® (trametinib) will be extended to include subsidy for post-surgery treatment for patients who have Stages IIIB, IIIC and IIID melanoma. 🔸 Gilenya® (fingolimod) will be amended to include a new strength of this medicine for…